ArticleBMC cancer2016

Erratum to: A phase 1b study of Selumetinib in combination with Cisplatin and Gemcitabine in advanced or metastatic biliary tract cancer: the ABC-04 study.

John Bridgewater et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.